Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

Zaki, Jihan K.; Lago, Santiago G.; Rustogi, Nitin; Gangadin, Shiral S.; Benacek, Jiri; van Rees, Geertje F.; Haenisch, Frieder; Broek, Jantine A.; Suarez-Pinilla, Paula; Ruland, Tillmann; Auyeung, Bonnie; Mikova, Olya; Kabacs, Nikolett; Arolt, Volker; Baron-Cohen, Simon; Crespo-Facorro, Benedicto; Drexhage, Hemmo A.; de Witte, Lot D.; Kahn, René S.; Sommer, Iris E.; Bahn, Sabine ; Tomasik, Jakub 

Tipo: Artículo
Año de Publicación: 2022
Volumen: 12
Número: 1
Número de artículo: 457
Acceso abierto: Vía dorada
Fuente Nº Citas Fecha Actualización
scopus203-06-2023
wos204-06-2023
Dimensions
PlumX
Altmetric

Año: 2021

Journal Impact Factor (JIF): 7,989

CategoríaEdiciónPosiciónCuartilTercilDecil
PSYCHIATRYSCIE24/155Q1T1D2

Año:

2021

CiteScore:

8,500

CategoríaPosiciónCuartilTercilDecil
Psychiatry and Mental Health45/529Q1T1D1
Biological Psychiatry9/43Q1T1D3
Cellular and Molecular Neuroscience19/88Q1T1D3

SJR año:

2022

Factor de Impacto:

2,148

CategoríaPosiciónCuartilTercilDecil
Biological Psychiatry3/47Q1T1D1
Psychiatry and Mental Health33/564Q1T1D1
Cellular and Molecular Neuroscience12/92Q1T1D2
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
Dutch Research Council (NWO)40-00812-98-12154
Engineering and Physical Sciences Research Council UK (EPSRC)-
FEDERPI16/00156
ISCIIIPI16/00156
MINECOSAF2016-76046-R; SAF2013-46292-R
Stanley Medical Research Institute12T-008
Stanley Medical Research Institute (SMRI)-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Zaki, Jihan K.Department of Chemical Engineering and Biotechnology (United Kingdom)
2Lago, Santiago G.Department of Chemical Engineering and Biotechnology (United Kingdom)
3Rustogi, NitinDepartment of Chemical Engineering and Biotechnology (United Kingdom)
4Gangadin, Shiral S.University of Groningen, University Medical Center Groningen (Netherlands)
5Benacek, JiriDepartment of Chemical Engineering and Biotechnology (United Kingdom)
6van Rees, Geertje F.Department of Chemical Engineering and Biotechnology (United Kingdom)
7Haenisch, FriederDepartment of Chemical Engineering and Biotechnology (United Kingdom)
8Broek, Jantine A.Department of Chemical Engineering and Biotechnology (United Kingdom)
9Suarez-Pinilla, PaulaHospital Universitario Marqués de Valdecilla; Centro de Investigación Biomédica En Red de Salud Mental (Spain)
10Ruland, TillmannUniversitätsklinikum Münster (Germany)
11Auyeung, BonnieAutism Research Centre (United Kingdom)
12Mikova, OlyaFoundation Biological Psychiatry (Bulgaria)
13Kabacs, NikolettCambridgeshire and Peterborough NHS Foundation Trust (United Kingdom)
14Arolt, VolkerUniversitätsklinikum Münster (Germany)
15Baron-Cohen, SimonAutism Research Centre (United Kingdom)
16Crespo-Facorro, BenedictoHospital Universitario Virgen del Rocío; Hospital Universitario Marqués de Valdecilla; Centro de Investigación Biomédica En Red de Salud Mental (Spain)
17Drexhage, Hemmo A.Erasmus MC (Netherlands)
18de Witte, Lot D.Icahn School of Medicine at Mount Sinai (United States)
19Kahn, René S.University Medical Center Utrecht; Icahn School of Medicine at Mount Sinai (United States)
20Sommer, Iris E.University of Groningen, University Medical Center Groningen (Netherlands)
21Bahn, Sabine Department of Chemical Engineering and Biotechnology (United Kingdom)
22Tomasik, Jakub Department of Chemical Engineering and Biotechnology (United Kingdom)